Cilgavimab Antibody
Cilgavimab (AZD-1061) is a human monoclonal antibody designed to neutralize SARS-CoV-2 by binding to its spike protein. It has been investigated in clinical studies for the treatment and prevention of COVID-19, demonstrating utility in both in vitro neutralization assays and in vivo therapeutic research.
Product Specifications
Product Name Alternative
COV22130, COV2-2130, AZD 5156, AZD1061, AZD-1061, AZD5156
Target
SARS-CoV
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Concentration
14.08 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
148.54 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
1958-AAT 2 Labelings
ReadiLink™ xtra Rapid iFluor® 555 Antibody Labeling Kit *BSA-Compatible*
Sign In for Pricing
View Details 
TA368079 100 µL
Mortality Factor 4 like 2 (MORF4L2) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
BNC043195-100 1x 100 µL
MCM7 (Proliferation Marker) (rMCM7/1468), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details